Drug-eluting stents below the knee

Journal of Cardiovascular Surgery

Volumn 52, Issue 2, 2011, Pages 231-234

  Bosiers, M ^a   Deloose, K ^a   Callaert, J ^a   Keirse, K ^b   Verbist, J ^b   Peeters, P ^b  

^a AZ Sint Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Hyperplasia; Stents; Treatment outcome

Indexed keywords

BX SONIC; CYPHER; CYPHER SELECT; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG; VISION (DRUG);

ANGIOGRAPHY; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTERY OCCLUSION; COLOR ULTRASOUND FLOWMETRY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; INFRAPOPLITEAL ARTERIAL OCCLUSIVE LESION; INFRAPOPLITEAL ARTERY LESION; ISCHEMIA; ISCHEMIC INFRAPOPLITEAL ARTERIAL DISEASE; LIMB SALVAGE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; LEG; PERIPHERAL ARTERIAL DISEASE; PROSTHESIS DESIGN; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 79957663522     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Randon C, Jacobs B, De Ryck F, Vermassen F. Angioplasty or primary stenting for infrapopliteal lesions: Results of a prospective randomized trial. Cardiovasc Intervent Radiol 2010;33:260-9.
2. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009;50:799-805.
3. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience. J Vasc Surg 2005;41:423-35. (Pubitemid 40523584)
4. Kuusela J, Manninen HI, Karhapää P. Infrapopliteal balloon angioplasty for chronic critical limb ischemia in diabetic patients with uremia: When is it worth the effort? J Vasc Inter Radiol 2009;20:342-6.
5. Rand T, Basile A, Cejna M, Fleischmann D, Funovics M, Gschwendtner M et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 2006;29:29-38. (Pubitemid 43128136)
6. Mauri L, Orav E, Candia S, Cutlip D, Kuntz R. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 2005;112:2833-9. (Pubitemid 41641678)
7. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 2006;92:641-9.
8. Hill R, Bagust A Bakhai A, Dickson R, Dündar Y, Haycox A et al. Liverpool Reviews and Implementation Group, Liverpool, UK. Health Technol Assess 2004;8:142-242.
9. Duda S, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10.
10. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. Am Coll Cardiol 2004;44:2307-14. (Pubitemid 39647603)
11. Scheinert D, Ulrich M, Scheinert S, Sax J, Bräunlich S, Biamino G et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2006;2:169-74.
12. Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005;12:685-95. (Pubitemid 43100926)
13. Bosiers M, Deloose K, Verbist J, Peelers P. Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino) 2006;47:171-6.
14. Commeau P, Barragan P, Roquebert P. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006;68:793-8. (Pubitemid 44721107)
15. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007;14:241-50. (Pubitemid 46776123)
16. Scheinert D, Ulrich M, Scheinert S, Sax J, Bräunlich S, Biamino G et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2006;2:169-74.
17. Scheinert D. Achilles study - randomized comparison of Sirolimus eluting stents vs. PTA for BTK obstructions. Leipzig Interventional Course 2011, Leipzig.
18. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Christeas N, Kagadis GC. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol 2007;18:1351-61. (Pubitemid 350010920)
19. Bosiers M. Drug-eluting stents below the knee - promises and limitations: update on the DESTINY trial comparing DES to BMS. VEITHsymposium 2010, New York, NY, USA.
20. Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M et al. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 2005;96:1251-3. (Pubitemid 41505403)